Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase II, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability and efficacy study of add-on Cladribine tablet therapy with Rebif New Formulation in Multiple Scleroris Subjects with Active Disease https://kusajili.fr:443/Trial/Llc761JyDE2PFuC31rT-Bg%24a-phase-ii-multicenter-randomized-double-blind-placebo-controlled-safety-tolerability-and-efficacy-study-of-add-on-cladribine-t
I have read and accept the terms of use of the site and the Privacy Policy
Send your message